Mapping genes that contribute to daunorubicin-induced cytotoxicity

作者：Duan, Shiwei; Bleibel, Wasim K.; Huang, Rong Stephanie; Shukla, Sunita J.; Wu, Xiaolin; Badner, Judith A.; Dolan, M. Eileen^*

来源：Cancer Research, 2007, 67(11): 5425-5433.

DOI：10.1158/0008-5472.CAN-06-4431

• ACUTE LYMPHOBLASTIC-LEUKEMIA
• LINKAGE ANALYSIS
• CELL-LINES
• ANTICANCER AGENTS
• INDUCED APOPTOSIS
• DRUG-RESISTANCE
• EXPRESSION
• DOXORUBICIN
• INHIBITION
• MDR1

Datmorubicin is an anthracycline antibiotic agent used in the treatment of hernatopoietic malignancies. Toxicities associated with this agent include myelosuppression and cardiotoxicity; however, the genes or genetic determinants that contribute to these toxicities are unknown. We present an unbiased genome-wide approach that incorporates heritability, whole-genome linkage analysis, and linkage-directed association to uncover genetic variants contributing to the sensitivity to daunorubicin-induced cytotoxicity. Cell growth inhibition in 324 Centre d' Etude du Polymorphisme Humain lymphoblastoid cell lines (24 pedigrees) was evaluated following treatment with daunorubicin for 72 h. Heritability analysis showed a significant genetic component contributing to the cytotoxic phenotypes (h(2) = 0.18-0.63 at 0.0125, 0.025, 0.05, 0.1, 0.2, and 1.0 mu mol/L daunorubicin and at the IC50, the dose required to inhibit 50% cell growth). Whole-genome linkage scans at all drug concentrations and IC50 uncovered 11 regions with moderate peak LOD scores (> 1.5), including 4q28.2 to 4q32.3 with a maximum LOD score of 3.18. The quantitative transmission disequilibrium tests were done using 31,312 high-frequency single-nucleotide polymorphisms (SNP) located in the I LOD confidence interval of these I I regions. Thirty genes were identified as significantly associated with daunorubicin-induced cytotoxicity (P <= 2.0 x 10(-4), false discovery rate:5 0.1). Pathway and functional gene ontology analysis showed that these genes were overrepresented in the phosphatidylinositol signaling system, axon guidance pathway, and GPI-anchored proteins family. Our findings suggest that a proportion of susceptibility to daunorubicin-induced cytotoxicity may be controlled by genetic determinants and that analysis using linkage-directed association studies with dense SNP markers can be used to identify the genetic variants contributing to cytotoxicity.

• 出版日期2007-6-1